VERTEX PHARMACEUTICALS INC / MA financials

  1. Home
  2. Company Facts
  3. VRTX
VRTX CIK 0000875320

Source: EDGAR filings · raw companyfacts JSON · Built 2026-04-25T10:20:49Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 3.19B -790.30M 3.34B 3.93B 2.41B 2.99B
EBITDA 4.38B -25.70M 4.01B 4.46B 2.91B 2.97B
Working Capital 7.34B 6.03B 10.60B 10.49B 7.42B 6.26B
Net Debt -3.05B -2.82B -9.56B -9.60B -5.83B -5.05B
Gross Margin 86.24% 86.11% 87.21% 87.90% 88.06% 88.14%
Operating Margin 34.77% -2.11% 38.83% 48.23% 36.73% 46.03%
Net Margin 32.94% -4.86% 36.68% 37.20% 30.92% 43.70%
Return on Equity (ROE) 21.18% -3.26% 20.59% 23.88% 23.19% 31.22%
Return on Assets (ROA) 15.42% -2.38% 15.92% 18.30% 17.44% 23.07%
Current Ratio 2.9009 2.6921 3.9872 4.8265 4.4634 4.332
Debt-to-Equity 0.1091 0.1066 0.046 0.0647 0.0958 0.1085
Effective Tax Rate 14.86% 315.53% 17.36% 21.51% 14.22% 13.00%
Cash Conversion Ratio 0.9186 0.9197 0.9773 1.2432 1.1287 1.1998
Accruals Ratio 0.0125 -0.0019 0.0036 -0.0445 -0.0224 -0.0461
SBC % of Revenue 5.72% 6.34% 5.89% 5.50% 5.83% 6.92%
CapEx Coverage 8.2984 -1.6547 17.6512 20.1754 11.2489 12.5231
Free Cash Flow Per Share $12.38 $-3.06 $12.81 $15.15 $9.27 $11.37

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 29.5927 — 29.2937 22.5257 24.3729 22.9679
P/FCF 36.623 — 31.7645 19.0621 23.697 20.7943
FCF Yield 2.73% — 3.15% 5.25% 4.22% 4.81%
EV / EBITDA 25.5757 — 23.7443 14.5018 17.215 19.0089
P/S 9.5947 9.3892 10.6243 8.3106 7.378 9.8977
P/B 6.169 6.3054 5.9642 5.3347 5.533 7.0708

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 12.00B 11.02B 9.87B 8.93B 7.57B 6.21B
Cost of Goods and Services Sold 1.65B 1.53B 1.26B 1.08B 904.20M 736.30M
Research and Development Expense — — — — 3.05B 1.83B
Selling, General and Administrative Expense 1.75B 1.46B 1.14B 944.70M 840.10M 770.50M
Operating Income (Loss) 4.17B -232.90M 3.83B 4.31B 2.78B 2.86B
Income Tax Expense (Benefit) 690.00M 784.10M 760.20M 910.40M 388.30M 405.20M
Net Income (Loss) Attributable to Parent 3.95B -535.60M 3.62B 3.32B 2.34B 2.71B
Earnings Per Share, Basic $15.46 $-2.08 $14.05 $12.97 $9.09 $10.44
Weighted Average Number of Shares Outstanding, Basic 255.70M 257.90M 257.70M 256.10M 257.70M 259.80M
Earnings Per Share, Diluted $15.32 $-2.08 $13.89 $12.82 $9.01 $10.29
Weighted Average Number of Shares Outstanding, Diluted 258.00M 257.90M 260.50M 259.10M 259.90M 263.40M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 5.08B 4.57B 10.37B 10.50B 6.79B 5.99B
Assets, Current 11.20B 9.60B 14.14B 13.23B 9.56B 8.13B
Assets 25.64B 22.53B 22.73B 18.15B 13.43B 11.75B
Liabilities, Current 3.86B 3.56B 3.55B 2.74B 2.14B 1.88B
Liabilities 6.98B 6.12B 5.15B 4.24B 3.33B 3.06B
Stockholders' Equity Attributable to Parent 18.67B 16.41B 17.58B 13.91B 10.10B 8.69B
Common Stock, Shares, Outstanding 253.99M 256.94M 257.70M 257.01M 254.48M 259.89M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 3.63B -492.60M 3.54B 4.13B 2.64B 3.25B
Payments to Acquire Property, Plant, and Equipment 437.60M 297.70M 200.40M 204.70M 235.00M 259.80M
Net Cash Provided by (Used in) Investing Activities -945.40M -3.77B -3.14B -321.10M -340.90M 99.40M
Payments for Repurchase of Common Stock 2.02B 1.18B 427.60M 0 1.43B 539.10M
Net Cash Provided by (Used in) Financing Activities -2.26B -1.49B -562.20M -67.70M -1.48B -505.30M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Income Statement

24 concepts 3 units
Unit US$ · 20 concepts
Label Value Period
Revenue from Contract with Customer, Excluding Assessed Tax 12.00B 2025-01-01 → 2025-12-31
Sublease Income 200.00K 2025-01-01 → 2025-12-31
Cost of Goods and Services Sold 1.65B 2025-01-01 → 2025-12-31
Research and Development Expense (Excluding Acquired in Process Cost) 3.91B 2025-01-01 → 2025-12-31
Research and Development Asset Acquired Other than Through Business Combination, Written-off 133.00M 2025-01-01 → 2025-12-31
Costs and Expenses 7.83B 2025-01-01 → 2025-12-31
Amortization of Intangible Assets 20.20M 2025-01-01 → 2025-12-31
Finance Lease, Right-of-Use Asset, Amortization 7.20M 2025-01-01 → 2025-12-31
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 379.00M 2025-01-01 → 2025-12-31
Advertising Expense 202.80M 2025-01-01 → 2025-12-31
Selling, General and Administrative Expense 1.75B 2025-01-01 → 2025-12-31
Operating Income (Loss) 4.17B 2025-01-01 → 2025-12-31
Investment Income, Interest and Dividend 490.90M 2025-01-01 → 2025-12-31
Foreign Currency Transaction Gain (Loss), before Tax -13.70M 2025-01-01 → 2025-12-31
Other Nonoperating Income (Expense) -7.70M 2025-01-01 → 2025-12-31
Finance Lease, Interest Expense 5.70M 2025-01-01 → 2025-12-31
InterestExpenseNonoperating 13.30M 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.64B 2025-01-01 → 2025-12-31
Income Tax Expense (Benefit) 690.00M 2025-01-01 → 2025-12-31
Net Income (Loss) Attributable to Parent 3.95B 2025-01-01 → 2025-12-31
Unit shares · 2 concepts
Label Value Period
Weighted Average Number of Shares Outstanding, Basic 255.70M 2025-01-01 → 2025-12-31
Weighted Average Number of Shares Outstanding, Diluted 258.00M 2025-01-01 → 2025-12-31
Unit US$ / share · 2 concepts
Label Value Period
Earnings Per Share, Basic $15.46 2025-01-01 → 2025-12-31
Earnings Per Share, Diluted $15.32 2025-01-01 → 2025-12-31

Comprehensive Income

7 concepts 1 unit
Unit US$ · 7 concepts
Label Value Period
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent 27.50M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent 26.90M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent -198.10M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent -143.70M 2025-01-01 → 2025-12-31
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3.81B 2025-01-01 → 2025-12-31
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax -7.60M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent 56.00M 2025-01-01 → 2025-12-31

Balance Sheet

53 concepts 3 units
Unit US$ · 45 concepts
Label Value Period
Cash and Cash Equivalents, at Carrying Value 5.08B as of 2025-12-31
Equity Securities, FV-NI 16.60M as of 2025-12-31
Restricted Cash and Cash Equivalents 3.00M as of 2025-12-31
Marketable Securities, Current 1.52B as of 2025-12-31
Accounts Receivable, after Allowance for Credit Loss, Current 2.05B as of 2025-12-31
Inventory, Net 1.69B as of 2025-12-31
Prepaid Expense, Current 101.70M as of 2025-12-31
Other Assets, Current 110.90M as of 2025-12-31
Assets, Current 11.20B as of 2025-12-31
Operating Lease, Right-of-Use Asset 1.56B as of 2025-12-31
Finance Lease, Right-of-Use Asset, after Accumulated Amortization 81.50M as of 2025-12-31
Capitalized Computer Software, Gross 66.60M as of 2025-12-31
Deferred Costs 318.40M as of 2025-12-31
Marketable Securities, Noncurrent 5.71B as of 2025-12-31
Goodwill 1.09B as of 2025-12-31
Finite-Lived Intangible Assets, Accumulated Amortization 46.10M as of 2025-12-31
Intangible Assets, Net (Excluding Goodwill) 424.20M as of 2025-12-31
Other Assets, Noncurrent 1.24B as of 2025-12-31
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued 95.70M as of 2025-12-31
Contract with Customer, Liability 171.80M as of 2025-12-31
Deferred Income Tax Assets, Net 2.90B as of 2025-12-31
Operating Lease, Liability 1.92B as of 2025-12-31
Assets 25.64B as of 2025-12-31
Accounts Payable, Current 461.70M as of 2025-12-31
Employee-related Liabilities, Current 397.70M as of 2025-12-31
Taxes Payable, Current 103.10M as of 2025-12-31
Accrued Liabilities, Current 2.97B as of 2025-12-31
Finance Lease, Liability 112.20M as of 2025-12-31
Business Combination, Contingent Consideration, Liability 79.00M as of 2025-12-31
Finance Lease, Liability, Current 5.50M as of 2025-12-31
Derivative Liability, Current 79.40M as of 2025-12-31
Other Liabilities, Current 428.30M as of 2025-12-31
Liabilities, Current 3.86B as of 2025-12-31
Finance Lease, Liability, Noncurrent 106.70M as of 2025-12-31
Other Liabilities, Noncurrent 1.27B as of 2025-12-31
Business Combination, Contingent Consideration, Liability, Noncurrent 79.00M as of 2025-12-31
Operating Lease, Liability, Noncurrent 1.85B as of 2025-12-31
Liabilities 6.98B as of 2025-12-31
Preferred Stock, Value, Issued 0 as of 2025-12-31
Common Stock, Value, Issued 2.50M as of 2025-12-31
Additional Paid in Capital, Common Stock 5.12B as of 2025-12-31
Accumulated Other Comprehensive Income (Loss), Net of Tax -15.90M as of 2025-12-31
Retained Earnings (Accumulated Deficit) 13.56B as of 2025-12-31
Stockholders' Equity Attributable to Parent 18.67B as of 2025-12-31
Liabilities and Equity 25.64B as of 2025-12-31
Unit shares · 6 concepts
Label Value Period
Preferred Stock, Shares Authorized 1.00M as of 2025-12-31
Preferred Stock, Shares Issued 0 as of 2025-12-31
Preferred Stock, Shares Outstanding 0 as of 2025-12-31
Common Stock, Shares Authorized 500.00M as of 2025-12-31
Common Stock, Shares, Issued 253.99M as of 2025-12-31
Common Stock, Shares, Outstanding 253.99M as of 2025-12-31
Unit US$ / share · 2 concepts
Label Value Period
Preferred Stock, Par or Stated Value Per Share $0.01 as of 2025-12-31
Common Stock, Par or Stated Value Per Share $0.01 as of 2025-12-31

Cash Flow Statement

37 concepts 1 unit
Unit US$ · 37 concepts
Label Value Period
Depreciation 155.80M 2025-01-01 → 2025-12-31
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities -116.90M 2025-01-01 → 2025-12-31
Depreciation, Depletion and Amortization 209.80M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Noncash Expense 685.90M 2025-01-01 → 2025-12-31
Finance Lease, Interest Payment on Liability 5.60M 2025-01-01 → 2025-12-31
Operating Lease, Payments 183.20M 2025-01-01 → 2025-12-31
Unrealized Gain (Loss) on Investments -11.30M 2025-01-01 → 2025-12-31
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.40M 2025-01-01 → 2025-12-31
Deferred Income Tax Expense (Benefit) -510.80M 2025-01-01 → 2025-12-31
IncomeTaxPaidFederalAfterRefundReceived 968.90M 2025-01-01 → 2025-12-31
IncomeTaxPaidStateAndLocalAfterRefundReceived 74.20M 2025-01-01 → 2025-12-31
Income Taxes Paid, Net 1.57B 2025-01-01 → 2025-12-31
Other Noncash Income (Expense) -113.40M 2025-01-01 → 2025-12-31
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 2.10M 2025-01-01 → 2025-12-31
Increase (Decrease) in Accounts Receivable 347.30M 2025-01-01 → 2025-12-31
Increase (Decrease) in Inventories 524.20M 2025-01-01 → 2025-12-31
Increase (Decrease) in Prepaid Expense and Other Assets 396.00M 2025-01-01 → 2025-12-31
Increase (Decrease) in Accounts Payable 36.80M 2025-01-01 → 2025-12-31
Increase (Decrease) in Other Deferred Liability -510.80M 2025-01-01 → 2025-12-31
Increase (Decrease) in Other Operating Liabilities 148.50M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Operating Activities 3.63B 2025-01-01 → 2025-12-31
Payments to Acquire Property, Plant, and Equipment 437.60M 2025-01-01 → 2025-12-31
Payments to Acquire Debt Securities, Available-for-sale 6.40B 2025-01-01 → 2025-12-31
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale 5.90B 2025-01-01 → 2025-12-31
ProceedsFromSaleOfEquitySecuritiesFvNi 16.00M 2025-01-01 → 2025-12-31
Payments for (Proceeds from) Other Investing Activities 24.70M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Investing Activities -945.40M 2025-01-01 → 2025-12-31
Finance Lease, Principal Payments 5.40M 2025-01-01 → 2025-12-31
Proceeds from Stock Options Exercised 55.60M 2025-01-01 → 2025-12-31
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 127.70M 2025-01-01 → 2025-12-31
Payments for Repurchase of Common Stock 2.02B 2025-01-01 → 2025-12-31
Payment, Tax Withholding, Share-based Payment Arrangement 369.90M 2025-01-01 → 2025-12-31
Proceeds from (Payments for) Other Financing Activities 3.70M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Financing Activities -2.26B 2025-01-01 → 2025-12-31
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 90.90M 2025-01-01 → 2025-12-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 515.60M 2025-01-01 → 2025-12-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.09B as of 2025-12-31

Notes

131 concepts 5 units
Unit US$ · 106 concepts
Label Value Period
Current Federal Tax Expense (Benefit) 679.10M 2025-01-01 → 2025-12-31
Current State and Local Tax Expense (Benefit) 35.90M 2025-01-01 → 2025-12-31
Current Foreign Tax Expense (Benefit) 485.80M 2025-01-01 → 2025-12-31
Current Income Tax Expense (Benefit) 1.20B 2025-01-01 → 2025-12-31
Deferred Federal Income Tax Expense (Benefit) -527.00M 2025-01-01 → 2025-12-31
Deferred State and Local Income Tax Expense (Benefit) -22.10M 2025-01-01 → 2025-12-31
Capitalized Computer Software, Amortization 31.20M 2025-01-01 → 2025-12-31
Deferred Foreign Income Tax Expense (Benefit) 38.30M 2025-01-01 → 2025-12-31
Operating Lease, Liability, Current 77.30M as of 2025-12-31
Accrued Royalties, Current 276.70M as of 2025-12-31
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 13.10M 2025-01-01 → 2025-12-31
Prepaid Expense and Other Assets, Current 853.30M as of 2025-12-31
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization 2.72B as of 2025-12-31
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization 1.20B as of 2025-12-31
Other Accrued Liabilities, Current 46.70M as of 2025-12-31
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization 1.52B as of 2025-12-31
Share-based Payment Arrangement, Amount Capitalized 14.40M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Expense 685.90M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Expensed and Capitalized, Amount 685.90M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 975.10M 2025-01-01 → 2025-12-31
Equity Securities, FV-NI, Cost 25.00M as of 2025-12-31
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount -1.90M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Expense, after Tax 557.30M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Expense, Tax Benefit 128.60M 2025-01-01 → 2025-12-31
EffectiveIncomeTaxRateReconciliationFdiiAmount 58.50M 2025-01-01 → 2025-12-31
EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount 800.00K 2025-01-01 → 2025-12-31
Other Sundry Liabilities, Current 48.30M as of 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 154.40M 2025-01-01 → 2025-12-31
Other Sundry Liabilities, Noncurrent 188.40M as of 2025-12-31
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount 742.30M as of 2025-12-31
Inventory, Finished Goods, Net of Reserves 230.10M as of 2025-12-31
Inventory, Work in Process, Net of Reserves 1.20B as of 2025-12-31
Inventory, Raw Materials, Net of Reserves 259.80M as of 2025-12-31
Contract with Customer, Liability, Revenue Recognized 206.80M 2025-01-01 → 2025-12-31
Equity Securities, FV-NI, Unrealized Gain 0 2025-01-01 → 2025-12-31
Equity Securities, FV-NI, Unrealized Loss 8.40M 2025-01-01 → 2025-12-31
Property, Plant and Equipment, Gross, Period Increase (Decrease) -107.50M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 25.40M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 64.30M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount 61.90M 2025-01-01 → 2025-12-31
Debt Securities, Available-for-sale, Realized Gain (Loss) 0 2025-01-01 → 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year One 22.70M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Two 21.30M as of 2025-12-31
Loss Contingency Accrual 0 as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Three 20.20M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Four 20.20M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Five 20.20M as of 2025-12-31
Intangible Assets, Gross (Excluding Goodwill) 470.30M as of 2025-12-31
Long-Lived Assets 3.08B as of 2025-12-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss 9.70M as of 2025-12-31
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 369.90M 2025-01-01 → 2025-12-31
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax 600.00K as of 2025-12-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer 100.00K as of 2025-12-31
Debt Securities, Available-for-sale, Unrealized Loss Position 631.90M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 326.70M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 147.80M 2025-01-01 → 2025-12-31
Stock Repurchased During Period, Value 2.01B 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value 326.70M as of 2025-12-31
Deferred Tax Assets, Tax Credit Carryforwards 355.80M as of 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost 171.80M as of 2025-12-31
Operating Lease, Cost 194.70M 2025-01-01 → 2025-12-31
Variable Lease, Cost 50.10M 2025-01-01 → 2025-12-31
Lease, Cost 257.50M 2025-01-01 → 2025-12-31
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 311.00M 2025-01-01 → 2025-12-31
Finance Lease, Liability, to be Paid, Year One 10.50M as of 2025-12-31
Finance Lease, Liability, to be Paid, Year Two 11.80M as of 2025-12-31
Finance Lease, Liability, to be Paid, Year Three 12.20M as of 2025-12-31
Finance Lease, Liability, to be Paid, Year Four 12.50M as of 2025-12-31
Finance Lease, Liability, to be Paid, Year Five 12.80M as of 2025-12-31
Finance Lease, Liability, to be Paid, after Year Five 118.30M as of 2025-12-31
Finance Lease, Liability, Payment, Due 178.10M as of 2025-12-31
Finance Lease, Liability, Undiscounted Excess Amount 65.90M as of 2025-12-31
Deferred Tax Assets, in Process Research and Development 1.92B as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year One 155.20M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Two 196.90M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Three 193.30M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Four 139.90M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Five 197.80M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, after Year Five 2.32B as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid 3.20B as of 2025-12-31
Deferred Tax Assets, Other 233.50M as of 2025-12-31
Deferred Tax Assets, Gross 3.72B as of 2025-12-31
Deferred Tax Assets, Valuation Allowance 326.20M as of 2025-12-31
Deferred Tax Assets, Net of Valuation Allowance 3.40B as of 2025-12-31
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.05B as of 2025-12-31
Deferred Tax Liabilities, Gross 499.80M as of 2025-12-31
Deferred Tax Assets, Net 2.90B as of 2025-12-31
Deferred Tax Liabilities, Leasing Arrangements 312.70M as of 2025-12-31
OCI, before Reclassifications, Net of Tax, Attributable to Parent -193.30M 2025-01-01 → 2025-12-31
Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent -49.60M 2025-01-01 → 2025-12-31
Deferred Tax Liabilities, Other 187.10M as of 2025-12-31
Cash Flow Hedge Derivative Instrument Assets at Fair Value 6.20M as of 2025-12-31
Defined Contribution Plan, Cost 63.10M 2025-01-01 → 2025-12-31
Debt Securities, Available-for-sale, Allowance for Credit Loss 0 as of 2025-12-31
Unrecognized Tax Benefits 852.10M as of 2025-12-31
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions 5.20M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 5.70M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 119.50M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 6.30M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 10.70M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation 43.90M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Period Increase (Decrease) 145.90M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits that Would Impact Effective Tax Rate 436.60M as of 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Domestic 2.82B 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Foreign 1.82B 2025-01-01 → 2025-12-31
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 700.30M 2025-01-01 → 2025-12-31
Unit shares · 6 concepts
Label Value Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1.15M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 7,000 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 447,000 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 1.15M as of 2025-12-31
Stock Repurchased During Period, Shares 4.80M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding 1.15M as of 2025-12-31
Unit US$ / share · 6 concepts
Label Value Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $170.54 as of 2025-12-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $502.97 2025-01-01 → 2025-12-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $125.30 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $170.54 as of 2025-12-31
Share Price $453.36 as of 2025-12-31
Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price $170.54 as of 2025-12-31
Unit pure · 12 concepts
Label Value Period
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent 0 2025-01-01 → 2025-12-31
EffectiveIncomeTaxRateReconciliationFdiiPercent 0.013 2025-01-01 → 2025-12-31
EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent 0 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 0.033 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 0.005 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 0.014 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent 0.013 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Percent 0.149 2025-01-01 → 2025-12-31
Finance Lease, Weighted Average Discount Rate, Percent 0.0451 as of 2025-12-31
Operating Lease, Weighted Average Discount Rate, Percent 0.0475 as of 2025-12-31
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 0.6 2025-01-01 → 2025-12-31
Unit segment · 1 concept
Label Value Period
Number of Operating Segments 1 2025-01-01 → 2025-12-31

Other

1 concepts 1 unit
Unit US$ · 1 concept
Label Value Period
Stock Issued During Period, Value, Employee Benefit Plan 127.90M 2025-01-01 → 2025-12-31

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (VRTX CIK 0000875320), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.